NCT04709406

Determinants on Rocuronium Dose for Deep Block in Bariatric Surgery

Analysis of Determinants on the Dose of Rocuronium for Deep Neuromuscular Blockade in Bariatric Surgery.

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 90 (estimated)
• Sponsor: Seoul National University Bundang Hospital · Academic / Other
• Sex: All
• Age: 20 Years – 80 Years
• Healthy volunteers: Accepted

Summary

Find out the deciding factor(total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index, skeletal muscle mass, body fat) of neuromuscular blocker dose for deep neuromuscular blockade in bariatric surgery.

Detailed description

Before the surgery, total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index were measured by height and weight and skeletal muscle mass and body fat were measured by Bioelectrical impedance analysis (InbodyH20B). Find the highest correlation between the 8 factors (total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index, skeletal muscle mass, body fat) and the amount of rocuronium administered to deep neuromuscular blockade in bariatric surgery.

Conditions

• Bariatric Surgery

Interventions

Type	Name	Description
DRUG	deep neuromuscular blockade in bariatric surgery	obese patients who underwent bariatric surgery

Timeline

• Start date: 2021-01-01
• Primary completion: 2021-10-01
• Completion: 2021-10-01
• First posted: 2021-01-14
• Last updated: 2021-01-14

Regulatory

• FDA-regulated drug study